Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Domenis 2011 J Bioenerg Biomembr"

From Bioblast
 
(8 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{{Publication
{{Publication
|title=Domenis R, Comelli M, Bisetto E, Mavelli I (2011) Mitochondrial bioenergetic profile and responses to metabolic inhibition in human hepatocarcinoma cell lines with distinct differentiation characteristics. J. Bioenerg. Biomembr43: 493-505.
|title=Domenis R, Comelli M, Bisetto E, Mavelli I (2011) Mitochondrial bioenergetic profile and responses to metabolic inhibition in human hepatocarcinoma cell lines with distinct differentiation characteristics. J Bioenerg Biomembr 43: 493-505.
|info=[http://www.ncbi.nlm.nih.gov/pubmed/21882038 PMID:21882038 ]
|info=[http://www.ncbi.nlm.nih.gov/pubmed/21882038 PMID:21882038 ]
|authors=Domenis R, Comelli M, Bisetto E, Mavelli I
|authors=Domenis R, Comelli M, Bisetto E, Mavelli I
|year=2011
|year=2011
|journal=J. Bioenerg. Biomembr.
|journal=J Bioenerg Biomembr
|abstract=The classical view of tumour cell bioenergetics has been recently revised. Then, the definition of the mitochondrial profile is considered of fundamental importance for the development of anti-cancer therapies, but it still needs to be clarified. We investigated two human hepatocellular carcinoma cell lines: the partially differentiated HepG2 and the undifferentiated JHH-6. High-resolution respirometry revealed a marked impairment/uncoupling of OXPHOS in JHH-6 compared with HepG2, with the phosphorylation system limiting the capacity for electron transport much more in JHH-6. Blocking glycolysis or mitochondrial ATP synthase we demonstrated that in JHH-6 ATP synthase functions in reverse and consumes glycolytic ATP, thereby sustaining ΔΨm. A higher expression level of ATP synthase Inhibitor Factor 1 (IF1), a higher extent of IF1 bound to ATP synthase and a lower ATPase/synthase capacity were documented in JHH-6. Thus, here IF1 appears to down-regulate the reverse mode of ATPsynthase activity, thereby playing a crucial role in controlling energy waste and ΔΨm. These results, while confirming the over-expression of IF1 in cancer cells, are the first to indicate an inverse link between cell differentiation status and IF1 (expression level and regulatory function).
|abstract=The classical view of tumour cell bioenergetics has been recently revised. Then, the definition of the mitochondrial profile is considered of fundamental importance for the development of anti-cancer therapies, but it still needs to be clarified. We investigated two human hepatocellular carcinoma cell lines: the partially differentiated HepG2 and the undifferentiated JHH-6. High-resolution respirometry revealed a marked impairment/uncoupling of OXPHOS in JHH-6 compared with HepG2, with the phosphorylation system limiting the capacity for electron transport much more in JHH-6. Blocking glycolysis or mitochondrial ATP synthase we demonstrated that in JHH-6 ATP synthase functions in reverse and consumes glycolytic ATP, thereby sustaining ΔΨm. A higher expression level of ATP synthase Inhibitor Factor 1 (IF1), a higher extent of IF1 bound to ATP synthase and a lower ATPase/synthase capacity were documented in JHH-6. Thus, here IF1 appears to down-regulate the reverse mode of ATPsynthase activity, thereby playing a crucial role in controlling energy waste and ΔΨm. These results, while confirming the over-expression of IF1 in cancer cells, are the first to indicate an inverse link between cell differentiation status and IF1 (expression level and regulatory function).
|mipnetlab=IT_Udine_Comelli_M
|mipnetlab=IT_Udine_Grassi B, IT Udine Mavelli I,
}}
}}
{{Labeling
{{Labeling
|organism=Human
|tissues=Liver
|preparations=Intact cells
|diseases=Cancer
|couplingstates=OXPHOS
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|injuries=Cancer; Apoptosis; Cytochrome c
|organism=Human
|tissues=Hepatocyte; Liver
|preparations=Intact Cell; Cultured; Primary
|topics=Respiration; OXPHOS; ETS Capacity, Coupling; Membrane Potential
}}
}}

Latest revision as of 15:09, 3 December 2013

Publications in the MiPMap
Domenis R, Comelli M, Bisetto E, Mavelli I (2011) Mitochondrial bioenergetic profile and responses to metabolic inhibition in human hepatocarcinoma cell lines with distinct differentiation characteristics. J Bioenerg Biomembr 43: 493-505.

» PMID:21882038

Domenis R, Comelli M, Bisetto E, Mavelli I (2011) J Bioenerg Biomembr

Abstract: The classical view of tumour cell bioenergetics has been recently revised. Then, the definition of the mitochondrial profile is considered of fundamental importance for the development of anti-cancer therapies, but it still needs to be clarified. We investigated two human hepatocellular carcinoma cell lines: the partially differentiated HepG2 and the undifferentiated JHH-6. High-resolution respirometry revealed a marked impairment/uncoupling of OXPHOS in JHH-6 compared with HepG2, with the phosphorylation system limiting the capacity for electron transport much more in JHH-6. Blocking glycolysis or mitochondrial ATP synthase we demonstrated that in JHH-6 ATP synthase functions in reverse and consumes glycolytic ATP, thereby sustaining ΔΨm. A higher expression level of ATP synthase Inhibitor Factor 1 (IF1), a higher extent of IF1 bound to ATP synthase and a lower ATPase/synthase capacity were documented in JHH-6. Thus, here IF1 appears to down-regulate the reverse mode of ATPsynthase activity, thereby playing a crucial role in controlling energy waste and ΔΨm. These results, while confirming the over-expression of IF1 in cancer cells, are the first to indicate an inverse link between cell differentiation status and IF1 (expression level and regulatory function).


O2k-Network Lab: IT_Udine_Grassi B, IT Udine Mavelli I


Labels: Pathology: Cancer 

Organism: Human  Tissue;cell: Liver  Preparation: Intact cells 


Coupling state: OXPHOS 

HRR: Oxygraph-2k